黑色素瘤免疫疗法的新方法。 - Suppr

Suppr

超能文献

New approach to immunotherapy of melanoma.

作者信息

Brandes L J, Galton D A, Wiltshaw E

出版信息

Lancet. 1971 Aug 7;2(7719):293-5. doi: 10.1016/s0140-6736(71)91336-5.

DOI:10.1016/s0140-6736(71)91336-5

PMID:4104979

Abstract

摘要

相似文献

New approach to immunotherapy of melanoma.

Lancet. 1971 Aug 7;2(7719):293-5. doi: 10.1016/s0140-6736(71)91336-5.

Immunotherapy in patients with melanoma.

Ann Surg. 1973 Sep;178(3):352-9. doi: 10.1097/00000658-197309000-00015.

Immunologic aspects of osteosarcoma and their application to therapy. A preliminary report.

J Bone Joint Surg Am. 1972 Oct;54(7):1367-97.

[Problems of the immunotherapy of malignant neoplasma].

Klin Med (Mosk). 1975 May;52(5):15-22.

Tumor-directed immune reactivity and immunotherapy in malignant melanoma. Current status.

Prog Exp Tumor Res. 1974;19:222-52. doi: 10.1159/000395859.

The present status of tumor immunology.

Adv Surg. 1971;5:189-254.

Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.

Semin Oncol. 1975 Jun;2(2):155-74.

Adoptive transfer and specific active immunization of patients with malignant melanoma.

Ann N Y Acad Sci. 1976;277(00):522-32. doi: 10.1111/j.1749-6632.1976.tb41726.x.

Results of administering B.C.G. to patients with melanoma.

Lancet. 1974 Nov 9;2(7889):1096-100. doi: 10.1016/s0140-6736(74)90867-8.

Lymphocyte-mediated immune responses in neoplasia.

Am J Clin Pathol. 1974 Aug;62(2):184-211. doi: 10.1093/ajcp/62.2.184.

引用本文的文献

Transfer factor in restoration of cell mediated immunity in lung cancer patients.

Jpn J Surg. 1983 Jul;13(4):304-11. doi: 10.1007/BF02469511.

Randomized controlled trial of transfer factor immunochemotherapy as an adjunct to surgical treatment for primary adenocarcinoma of the lung.

Jpn J Surg. 1984 Nov;14(6):452-8. doi: 10.1007/BF02469786.

Editorial: Transfer factor.

Br Med J. 1974 May 25;2(5916):397-8.

In vitro properties of leukocyte dialysates containing transfer factor.

Proc Natl Acad Sci U S A. 1974 Apr;71(4):1178-82. doi: 10.1073/pnas.71.4.1178.

Effects of dialyzable transfer factor in patients with breast cancer.

Proc Natl Acad Sci U S A. 1974 Jun;71(6):2319-23. doi: 10.1073/pnas.71.6.2319.

Histological evidence of tumour rejection after active immunotherapy in human malignant disease.

Br Med J. 1972 Apr 22;2(5807):183-8. doi: 10.1136/bmj.2.5807.183.

The role of immunotherapy in the management of patients with malignant melanoma.

World J Surg. 1979 Jul 30;3(3):309-20. doi: 10.1007/BF01556582.

[The immunology of malignant melanoma (author's transl)].

Klin Wochenschr. 1978 Mar 15;53(16):241-53.

Transfer factor: a potential agent for immunotherapy of cancer.

World J Surg. 1977 Sep;1(5):617-23. doi: 10.1007/BF01556190.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

New approach to immunotherapy of melanoma.

作者信息

Brandes L J, Galton D A, Wiltshaw E

出版信息

Lancet. 1971 Aug 7;2(7719):293-5. doi: 10.1016/s0140-6736(71)91336-5.

DOI:10.1016/s0140-6736(71)91336-5

PMID:4104979

Abstract

摘要

相似文献

New approach to immunotherapy of melanoma.

Lancet. 1971 Aug 7;2(7719):293-5. doi: 10.1016/s0140-6736(71)91336-5.

Immunotherapy in patients with melanoma.

Ann Surg. 1973 Sep;178(3):352-9. doi: 10.1097/00000658-197309000-00015.

Immunologic aspects of osteosarcoma and their application to therapy. A preliminary report.

J Bone Joint Surg Am. 1972 Oct;54(7):1367-97.

[Problems of the immunotherapy of malignant neoplasma].

Klin Med (Mosk). 1975 May;52(5):15-22.

Tumor-directed immune reactivity and immunotherapy in malignant melanoma. Current status.

Prog Exp Tumor Res. 1974;19:222-52. doi: 10.1159/000395859.

The present status of tumor immunology.

Adv Surg. 1971;5:189-254.

Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.

Semin Oncol. 1975 Jun;2(2):155-74.

Adoptive transfer and specific active immunization of patients with malignant melanoma.

Ann N Y Acad Sci. 1976;277(00):522-32. doi: 10.1111/j.1749-6632.1976.tb41726.x.

Results of administering B.C.G. to patients with melanoma.

Lancet. 1974 Nov 9;2(7889):1096-100. doi: 10.1016/s0140-6736(74)90867-8.

Lymphocyte-mediated immune responses in neoplasia.

Am J Clin Pathol. 1974 Aug;62(2):184-211. doi: 10.1093/ajcp/62.2.184.

引用本文的文献

Transfer factor in restoration of cell mediated immunity in lung cancer patients.

Jpn J Surg. 1983 Jul;13(4):304-11. doi: 10.1007/BF02469511.

Randomized controlled trial of transfer factor immunochemotherapy as an adjunct to surgical treatment for primary adenocarcinoma of the lung.

Jpn J Surg. 1984 Nov;14(6):452-8. doi: 10.1007/BF02469786.

Editorial: Transfer factor.

Br Med J. 1974 May 25;2(5916):397-8.

In vitro properties of leukocyte dialysates containing transfer factor.

Proc Natl Acad Sci U S A. 1974 Apr;71(4):1178-82. doi: 10.1073/pnas.71.4.1178.

Effects of dialyzable transfer factor in patients with breast cancer.

Proc Natl Acad Sci U S A. 1974 Jun;71(6):2319-23. doi: 10.1073/pnas.71.6.2319.

Histological evidence of tumour rejection after active immunotherapy in human malignant disease.

Br Med J. 1972 Apr 22;2(5807):183-8. doi: 10.1136/bmj.2.5807.183.

The role of immunotherapy in the management of patients with malignant melanoma.

World J Surg. 1979 Jul 30;3(3):309-20. doi: 10.1007/BF01556582.

[The immunology of malignant melanoma (author's transl)].

Klin Wochenschr. 1978 Mar 15;53(16):241-53.

Transfer factor: a potential agent for immunotherapy of cancer.

World J Surg. 1977 Sep;1(5):617-23. doi: 10.1007/BF01556190.